Solid Biosciences Inc
SLDB
Get informed when a big investor buys or sells
+ FollowMarket Cap$676.35M
Close$
$0.44
92.3% downside
Current Fair Value
92.3% downsideOvervalued by 92.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $676.35 Million |
|---|---|
| Enterprise Value | $537.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.99 |
| Beta | 2.47 |
| Outstanding Shares | 143,688,701 |
Return
| Return on Equity | -55.36% |
|---|---|
| Return on Assets | -49.24% |
| Return on Invested Capital | -53.46% |
Valuation & Multiples
| P/E Ratio | -3.6 |
|---|---|
| PEG | -9.27 |
| Price to Sales | - |
| Price to Book Ratio | 2.87 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.56 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.42
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$-0.37
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 7.90% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 79.88% |
|---|---|
| Total Invested | $60,385▼ 99.99% |
| Investors Holding | 4▼ 159.00% |
ESG Score
No data